# Estrella Immunopharma, Inc.: Form DEF 14A, filed May 27, 2026

- Company: [Estrella Immunopharma, Inc.](/companies/esla.md) (CIK 1844417)
- Form: DEF 14A
- Filed: 2026-05-27
- Accepted by EDGAR: May 27, 2026, 17:25 ET
- Period: 2026-06-29
- Accession: 0001140361-26-023012
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1844417/000114036126023012/ny20074256x1_def14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1844417/000114036126023012/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1844417/000114036126023012/ny20074256x1_def14a.htm

Filed May 27, 2026.
Source: SEC EDGAR, the filing index for accession 0001140361-26-023012. Last ingested by Listed: Nov 4, 2026, 07:37 ET. No prices; not investment advice.
